Notch: Of mice and men?

Blood

Volumn 116, Issue 25, 2010, Pages 5438-5439

  Malinge, Sebastien ^a   Crispino, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CD34 ANTIGEN; FIBRINOGEN RECEPTOR; NOTCH RECEPTOR;

CELL DIFFERENTIATION; COLONY FORMING UNIT; HEMATOPOIETIC STEM CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 78650442611     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-308395     Document Type: Note

References (5)

1. Mercher T, Cornejo MG, Sears C, et al. Notch signaling specifies megakaryocyte development from hematopoietic stem cells. Cell Stem Cell. 2008;3(3):314-326.
2. Poirault-Chassac S, Six E, Catelain C, et al. Notch/Delta4 signaling inhibits human megakaryocytic terminal differentiation. Blood. 2010;116(25):5670-5678.
3. Radtke F, Fasnacht N, Macdonald HR. Notch signaling in the immune system. Immunity. 2010;32(1):14-27.
4. Ishiko E, Matsumura I, Ezoe S, et al. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. J Biol Chem. 2005;280(6):4929-4939. (Pubitemid 40288668)
5. Mercher T, Raffel GD, Moore SA, et al. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. J Clin Invest. 2009;119(4):852-864.